Blood glucose test strips: options to reduce usage
- 21 December 2009
- journal article
- research article
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 182 (1) , 35-38
Abstract
Background: Recent evidence suggests that, despite widespread use, self-monitoring of blood glucose levels has little clinical benefit in many patients with diabetes. The impact of more focused public-payer policies for the use of blood glucose test strips may be substantial. Methods: We conducted a cross-sectional analysis of annual prescription claims for test strips between 1997 and 2008 for patients in Ontario aged 65 and older with diabetes. Patients were stratified into 1 of 4 hierarchical groups according to the most intensive glucose-lowering treatment received during each calendar year. Test strip use was calculated annually for each group over the study period, and the effects of 5 hypothetical policy scenarios of more selective test strip use were assessed. Results: Test strip use increased by almost 250% from 1997 to 2008, with 52.6% (n = 263 513) of included patients receiving a prescription during 2008. Almost half of these patients were at low risk for drug-induced hypoglycemia. In 2008, over 117 million test strips were dispensed in Ontario; however, more focused policy scenarios could have reduced this number by between 9.5 million and 74.5 million test strips. Interpretation: Many people who self-monitor their blood glucose are at relatively low risk for drug-induced hypoglycemia. The economic benefits associated with more selective testing could be redirected to more effective interventions for patients with diabetes.Keywords
This publication has 16 references indexed in Scilit:
- Systematic review of use of blood glucose test strips for the management of diabetes mellitus.2010
- Clinical and demographic characteristics of patients receiving different oral hypoglycemic agentsPharmacoepidemiology and Drug Safety, 2009
- Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trialBMJ, 2008
- Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trialBMJ, 2007
- Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes StudyDiabetologia, 2007
- Role of Self-Monitoring of Blood Glucose in Glycemic ControlEndocrine Practice, 2006
- Coding accuracy of administrative drug claims in the Ontario Drug Benefit database.2003
- Diabetes in OntarioDiabetes Care, 2002
- Self-Monitoring of Blood Glucose in Type 2 DiabetesDiabetes Care, 2001
- The Efficacy of Self-Monitoring of Blood Glucose in NIDDM subjects: A criteria-based literature reviewDiabetes Care, 1997